Sarah Beth Mackenzie, in Springfield, OR - Counselor

Sarah Beth Mackenzie, is a Counselor - Mental Health based in Springfield, Oregon. Sarah Beth Mackenzie is licensed to practice in * (Not Available) (license number ) and her current practice location is 3995 Marcola Rd, Springfield, Oregon. She can be reached at her office (for appointments etc.) via phone at (541) 689-3280.

NPI number for Sarah Beth Mackenzie is 1215642137 and her current mailing address is 3995 Marcola Rd, Springfield, Oregon. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1215642137.

Contact Information

	Sarah Beth Mackenzie,
	3995 Marcola Rd, Springfield, OR 97477-7948
	(541) 689-3280
	Not Available

Healthcare Provider's Profile

Full Name	Sarah Beth Mackenzie
Gender	Female
Speciality	Counselor - Mental Health
Location	3995 Marcola Rd, Springfield, Oregon
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1215642137
Provider Enumeration Date: 01/16/2023
Last Update Date: 08/31/2023

Medical Identifiers

Medical identifiers for Sarah Beth Mackenzie such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1215642137	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	(* (Not Available))	Secondary
101YM0800X	Counselor - Mental Health	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sarah Beth Mackenzie is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sarah Beth Mackenzie, 3995 Marcola Rd, Springfield, OR 97477-7948 Ph: (541) 460-1820	Sarah Beth Mackenzie, 3995 Marcola Rd, Springfield, OR 97477-7948 Ph: (541) 689-3280

News Archive

ResMed third quarter revenue increases 17% to $282.0 million

ResMed Inc. today announced record revenue and income for the quarter ended September 30, 2010. Revenue for the quarter ended September 30, 2010 was $282.0 million, a 14% increase (a 17% increase on a constant currency basis) over the quarter ended September 30, 2009.

Hybridon collaborates to develop immune modulatory (IMO) compounds for asthma and allergy

Hybridon today announced it had entered into research collaboration and license agreements with Novartis for the discovery, optimization, development and commercialization of Toll-like receptor 9 (TLR9) drug candidates targeting asthma and allergy based on Hybridon's proprietary immune modulatory oligonucleotide (IMO) technology platform.

Guiding nanoparticles directly to the tumor cells

Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue. An interdisciplinary team of researchers at Helmholtz-Zentrum Dresden-Rossendorf and FU Berlin has made important progress in this area: the scientists have produced tiny nanoparticles that are designed to specifically target cancer cells.

Nanobiotix, PharmaEngine partner to commercialize NBTXR3 for soft tissue sarcoma

PharmaEngine, Inc. announced today the execution of an exclusive license and collaboration agreement with France-based Nanobiotix S.A. for the development and commercialization of NBTXR3, currently being investigated in a phase I study with soft tissue sarcoma patients.

Sarah Beth Mackenzie, - in Springfield, OR